| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Grace Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10,000 | 08 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRCE | Grace Therapeutics, Inc. | 08 Jan 2026 | 1 | $0 | 4 | Director | 12 Jan 2026, 16:01 |
| GRCE | Grace Therapeutics, Inc. | 09 May 2025 | 1 | $0 | 4 | Director | 13 May 2025, 17:21 |
| GRCE | Acasti Pharma Inc. | 19 Dec 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 20 Dec 2023, 16:08 |
| GRCE | Acasti Pharma Inc. | 25 Sep 2023 | 2 | +$1,302,775 | 4 | Director, 10%+ Owner | 27 Sep 2023, 20:46 |
| GRCE | Acasti Pharma Inc. | 14 Jul 2023 | 1 | $0 | 4 | Director | 18 Jul 2023, 16:36 |
| GRCE | Acasti Pharma Inc. | 28 Sep 2022 | 1 | $0 | 4 | Director | 30 Sep 2022, 16:21 |
| GRCE | Acasti Pharma Inc. | 12 Nov 2021 | 1 | $0 | 4 | Director | 16 Nov 2021, 15:20 |
| GRCE | Acasti Pharma Inc. | 27 Aug 2021 | 0 | $0 | 3 | Director | 28 Sep 2021, 16:22 |